Global Pacemaker Devices Market Overview:
A pacemaker is a small implantable device that is placed in the chest or abdomen to help control abnormal heart rhythms. It consists of a battery-operated control unit (pulse generator) and lead wires that are threaded to the chambers of the heart and attached to the heart muscle that detects the heart rate and delivers small pulses of energy from the pulse generator to the heart. This device designed to keep the patient's heart from going too slowly and this helps the heart to pump more blood to the body.
Growth Drivers
- Increased Prevalence of Heart Diseases
- Technological Advancements in the Pacemaker Devices
- Development of New Diagnostic Centres and Hospitals
Roadblocks
- High Cost associated with Pacemaker Devices
- Less Awareness among People
Opportunities
- Increasing Research and Development Investments by Major Players
- Development of Healthcare Infrastructure in Emerging Economies
- Growing Focus on Preventive Healthcare
Challenges
- Risks Associated with Pacemaker Devices Implantation
Competitive Landscape:
Some of the key players profiled in the report are Boston Scientific Corporation (United Staes), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (United Kingdom), Medtronic PLC (Ireland), Abbott Laboratories (United Staes), Lepu Medical Technology Co Ltd (China), Medico, S.p.A (Italy), Osypka Medical GmbH (Germany), Shree Pacetronix Ltd. (India) and Cook Medical Group (United States). Additionally, following companies can also be profiled that are part of our coverage like St. Jude Medical Inc. (United States), Vitatron Holding B.V. (Netherlands) and ZOLL Medical Corporation (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Pacemaker Devices market by 2026. Considering Market by Technology, the sub-segment i.e. MRI Compatible Pacemakers will boost the Pacemaker Devices market. Considering Market by End-user, the sub-segment i.e. Hospitals & Cardiac Centers will boost the Pacemaker Devices market.
Latest Market Insights:
Recently, Abbott has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction provides Abbott with expanded opportunities for future growth and is an important part of the company's ongoing effort to develop a strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals.
On 21st January 2020, Medtronic plc has announced that it has received U.S. Food and Drug Administration (FDA) approval of Micra AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony. Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical signals between the chambers of the heart (the atria and the ventricle) are impaired.
What Can be Explored with the Pacemaker Devices Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Pacemaker Devices Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Pacemaker Devices
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Pacemaker Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Pacemaker Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Pacemaker Device Manufacturers, Research Professionals, Emerging Companies, Distributors, Government Body & Associations and End-user.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.